Blue Trust’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7K Buy
+118
New +$6.9K ﹤0.01% 1689
2025
Q4
– Sell
-80
Closed -$935 – 2729
2025
Q3
$935 Sell
80
-4,814
-98% -$62.8K ﹤0.01% 2339
2025
Q2
$56.7K Buy
4,894
+1,590
+48% +$14.5K ﹤0.01% 1370
2025
Q1
$28.8K Sell
3,304
-8
-0.2% -$101 ﹤0.01% 1561
2024
Q4
$47.6K Buy
3,312
+1,536
+86% +$24.2K ﹤0.01% 1344
2024
Q3
$34.5K Buy
1,776
+1,025
+136% +$21.2K ﹤0.01% 1725
2024
Q2
$28.2K Buy
751
+717
+2,109% +$18.8K ﹤0.01% 1515
2024
Q1
$1.28K Sell
34
-291
-90% -$12.8K ﹤0.01% 1896
2023
Q4
$13K Buy
+325
New +$14.1K ﹤0.01% 1494
2023
Q2
– Sell
-14
Closed -$1K – 2530
2023
Q1
$1K Sell
14
-29
-67% -$1.35K ﹤0.01% 2217
2022
Q4
$1K Buy
43
+31
+258% +$1.01K ﹤0.01% 2147
2022
Q3
$0 Buy
+12
New +$457 ﹤0.01% 2329

Other funds holding TXG

Blue Trust's TXG Position: Q3 2026 in Review

Blue Trust opened a new position in 10x Genomics (TXG) in Q3 2026: 118 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #1689 among its holdings. This is a return to the name: Blue Trust previously reported a position in TXG as recently as Q3 2025.

Blue Trust first reported a position in TXG in Q3 2022 and has held it in 12 quarters since. The position peaked at $56.7K in Q2 2025. 411 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Blue Trust held 118 shares of 10x Genomics worth $10.7K as of Q3 2026.
  • 10x Genomics was a new Blue Trust position in Q3 2026.
  • 10x Genomics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1689 holding.
  • Blue Trust first reported a position in 10x Genomics in Q3 2022 and has held it in 12 quarters since.
  • Blue Trust's 10x Genomics position peaked at $56.7K in Q2 2025.
  • 411 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.